Recent News

• 06.08.2026 - Dario Presents Four Studies at American Diabetes Association Scientific Sessions Highlighting Commercial and Clinical Value of its Digital Health Platform
• 05.13.2026 - DarioHealth Reports First Quarter 2026 Financial and Operating Results
• 05.04.2026 - DarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026
• 04.20.2026 - Dario Demonstrates Improved Workplace Function and Productivity Outcomes Through Digital Behavioral Health Program: Real-World Study Published in JMIR Formative Research
• 03.19.2026 - DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
• 03.11.2026 - DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026
• 03.10.2026 - Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health

Recent Filings

• 05.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.07.2026 - SD Specialized disclosure report
• 04.13.2026 - 3 Initial statement of beneficial ownership of securities
• 04.13.2026 - 8-K Current report
• 04.13.2026 - EX-99.1 EX-99.1
• 03.30.2026 - 8-K Current report
• 03.30.2026 - 424B5 Prospectus [Rule 424(b)(5)]
• 03.27.2026 - EFFECT Notice of Effectiveness
• 03.25.2026 - UPLOAD SEC-generated letter
• 03.25.2026 - CORRESP Correspondence